Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Speak with other shareholders about: (OTCBB: WWAT), (Nasdaq: CRTX), (OTCBB: ICPR), (OTCBB: DHNA), (PINK SHEETS: HMIT).
- M2 PRESSWIRE-31 May 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: WWAT), (Nasdaq: CRTX), (OTCBB: ICPR), (OTCBB: DHNA), (PINK SHEETS: HMIT)C1994-2007 M2 COMMUNICATIONS LTD RDATE:31052007 AUSTIN, TX - Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked...
- Research articles 2007-05-31
- Best Sales Tool: Smartphone or Notebook?
- Best Sales Tool: Smartphone or Notebook?Smartphone or Notebook?I don't think smartphones are up to the task for someone who must stay "connected." The issue -- screen size. (Sorry to hear about the stewardess's comment, Geoffrey. I feel your pain.)I'm a technology junkie (gadgets, hardware and software, too)....
- Discussion threads 2008-06-18
- Seniors, Disabled in Medicare's Coverage 'Donut Hole' Should Talk to Doctor about Switching to Cost-Effective Drugs ; Switching Could Save Hundreds a Month; Help Ensure They Still Get Needed Medicines
- WASHINGTON, Sept. 20 /U.S. Newswire/ -- As millions of seniors and disabled fall into the Medicare Part D "donut hole" coverage gap in coming weeks, Consumer Reports Best Buy Drugs urges beneficiaries to talk to their doctor about switching to cost- effective medications that will dramatically cut their out-of- pocket...
- Research articles 2006-09-20
- New Once-Daily Oral Diabetes Treatment Glumetza™ Now Available
- BRISTOL, Tenn. & MENLO PARK, Calif. -- - Novel Drug-Delivery Technology Enables Extended-Release Formulation to Combine Efficacy Benefits of Metformin with Once-Daily Dosing to Maximize Metformin Therapy - Adult patients living with type 2 diabetes now have a new treatment option available that may help them get the...
- Research articles 2006-09-06
- Nokia.(WHAT ENGINEERS WANT)(Brief article)
- Nokia's N800 series electronic tablet provides Internet access, instant messaging, e-mail, and Internet calling with optional video camera. The tablet is equipped with a high-resolution widescreen display, high-quality audio speakers and microphone, Nokia's N800 series electronic tablet provides Internet access, instant messaging, e-mail, and...
- Research articles 2007-10-01
- Depomed and King Pharmaceuticals Prepare for Launch of Glumetza™ as Timely, New ADA Guidelines Are Issued; Consensus Statement Recommends That Metformin Be Added to Lifestyle Changes as Initial Treatment for Type 2 Diabetes
- MENLO PARK, Calif. & BRISTOL, Tenn. -- Depomed, Inc. (NASDAQ:DEPO) and King Pharmaceuticals, Inc. (NYSE:KG) announced today that as they prepare for the launch of GlumetzaTM (metformin hydrochloride extended-release tablets), a new consensus statement was issued from the American Diabetes Association ADA and the European Association for the Study of...
- Research articles 2006-08-23
- Bloodstain reagent.(Forensics Showcase)
- A compact and lightweight multi-use product, each pack of BLUESTAR Forensic Tablets enables an investigator to prepare 4 ounces of BLUESTAR FORENSIC working solution eight times or up to 1 liter (32 ounces) if all tablets are used together. Each pack A compact and lightweight multi-use...
- Research articles 2007-04-01
- Visa and Tablet Hotels to Offer Elite Hotel Privileges at Exclusive Hotels Worldwide
- Tablet Plus Members Only Program Gives Select Visa Signature Cardholders Expanded Amenities at More Than 100 Tablet Hotels
- Research articles 2007-10-26
- Lupin Pharmaceuticals Inc. gets FDA go-ahead
- Lupin Pharmaceuticals Inc., an Indian company whose sales and marketing headquarters is in Baltimore, said it received permission from the Food and Drug Administration to market Amlodipine Beylate tablets, a generic drug used to treat high blood pressure. Commercial shipments of tablets in 2.5 milligram, 5 mg and 10 mg...
- Research articles 2007-07-19
- CDW-G Provides Fujitsu Tablets to Incoming Cadets at U.S. Air Force Academy
- Tablet Computers Selected After Rigorous Procurement Process, Meeting the Unique Needs of Future Air Force Officers
- Research articles 2007-08-07
- TEVA announces approval of Clarithromycin ER tablets, Pharmion Corporation to present at UBS Global Pharmaceuticals Conference.
- M2 PRESSWIRE-19 May 2005-US Financial Network: TEVA announces approval of Clarithromycin ER tablets, Pharmion Corporation to present at UBS Global Pharmaceuticals ConferenceC1994-2005 M2 COMMUNICATIONS LTD RDATE:19052005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC:...
- Research articles 2005-05-19
- Teva announces tentative approval of olanzapine tablets and Immunomedics' humanized anti-CD20 antibody effective in severe lupus.
- M2 PRESSWIRE-29 March 2005-US Financial Network: Teva announces tentative approval of olanzapine tablets and Immunomedics' humanized anti-CD20 antibody effective in severe lupusC1994-2005 M2 COMMUNICATIONS LTD RDATE:29032005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC:...
- Research articles 2005-03-29
- Baltimore-based Lupin drug receives OK from FDA
- Lupin Pharmaceuticals Inc., of Baltimore, the U.S. subsidiary of an Indian pharmaceutical manufacturer, said it received Food and Drug Administration approval of its application to market simvastatin tablets in 10, 20, 40 and 80 milligram doses. Lupin said its simvastatin tablets are the generic equivalent of Merck & Co.'s Zocor...
- Research articles 2007-05-16
- Desperate for headache tablets, man holds up pharmacy in Sweden
- STOCKHOLM AFP — A man brandishing a gun-like object held up a drugstore in the small southwestern Swedish town of Bollebygd and made off with his booty: a package of headache tablets, Swedish media reported. The man walked into the pharmacy, pulled out an object that resembled a gun...
- Research articles 2004-12-20
- IVAX to Begin Sale of Morphine Sulfate Controlled-Release Tablets C-II as Authorized Distributor
- MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that its U.S. generic subsidiary, IVAX Pharmaceuticals, Inc., will distribute, in the United States, morphine sulfate controlled-release tablets C-II in 15, 30, 60, 100 and 200 mg dosage strengths supplied by Purdue Pharma LP of Stamford, Connecticut. Morphine sulfate controlled-release tablets...
- Research articles 2005-07-29
- AuthenTec Adds Security to New Motion Computing Tablet PC
- New F5 Tablet is Motion's First Semi-Rugged, Fingerprint-Enabled Tablet PC Tailored for Today's Mobile Field Worker
- Research articles 2008-05-05
- IVAX Receives Final Approval for Doxycycline Hyclate Tablets
- MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for doxycycline hyclate 20 mg tablets. This product will be sold through IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc. Doxycycline hyclate 20 mg tablets...
- Research articles 2005-05-13
- Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
- MENLO PARK, Calif. -- Depomed, Inc. (NASDAQ:DEPO) announced today that it has filed a prior approval supplement with the U.S. Food and Drug Administration FDA seeking approval to market in the United States 1000 mg strength tablets of GlumetzaTMmetformin hydrochloride extended release tablets. The company expects the FDA to make...
- Research articles 2007-04-02
- UPEK Provides Biometric Fingerprint Security for the ThinkPad Tablet; Lenovo Expands Integration of UPEK Technology Across Notebook PC Product Line With Introduction of ThinkPad X41 Tablet
- BERKELEY, Calif. -- UPEKR, Inc., the leading supplier of biometric fingerprint security solutions, today announced that Lenovo has chosen UPEK's fingerprint authentication solutions to secure their ThinkPad* Series of notebooks with the introduction of the new ThinkPad X41 Tablet. Lenovo incorporated UPEK technology on select models of the ThinkPad X41...
- Research articles 2005-07-25
- WATSON PHARMACEUTICALS Inc.(Brief Article)
- WATSON PHARMACEUTICALS Inc.'s abbreviated new drug application for oxycodone and acetaminophen tablets has been approved by FDA. The tablets are USP, 7.5 ... WATSON PHARMACEUTICALS Inc.'s abbreviated new drug application for oxycodone and acetaminophen tablets has been approved by FDA. The tablets are...
- Research articles 2001-01-08
- << Previous
- page 1 of 14
- Next >>
Content Types
Refining Tags
- tablet PC (115 results)
- PC (101 results)
- FDA (42 results)
- Microsoft Corp. (27 results)
- Fujitsu Ltd. (20 results)
- notebook (17 results)
- Mobile (16 results)
- Computer (16 results)
- Hewlett-Packard Co. (13 results)
- Toshiba Corp. (12 results)
- Wireless (11 results)
- software (10 results)
- IVAX Corp. (9 results)
- patient (8 results)
- pharmaceutical company (6 results)
- Lenovo Group Ltd. (6 results)
- Intel Corp. (5 results)
- Corel Corp. (5 results)
- IBM ThinkPad (5 results)
- Nokia Corp. (5 results)
- NEC Corp. (5 results)
- Panasonic (4 results)
- Biovail Corp. (4 results)
- mobility (4 results)
- AstraZeneca Plc. (4 results)
- Merck & Co. Inc. (4 results)
- Hitachi Ltd. (4 results)
- Acer Inc. (4 results)
- Mobile Computer (4 results)
- processor (4 results)
- performance (4 results)
- multimedia (4 results)
- Handheld (4 results)
- environment (3 results)
- graphics (3 results)
- Compaq Computer Corp. (3 results)
- Microsoft Windows XP (3 results)
- Microsoft Windows (3 results)
- Transmeta Corp. (3 results)
- manufacturing (3 results)
- Nasdaq Stock Market Inc. (3 results)
- mobile computing (3 results)
- ViewSonic Corp. (3 results)
- operating system (3 results)
- MARKETING (3 results)
- camera (3 results)
- FINANCE (3 results)
- agreement (3 results)
- Pfizer Inc. (3 results)